Envista (NVST) Expected to Announce Earnings on Thursday

Envista (NYSE:NVST) is anticipated to post its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect the company to announce earnings of $0.32 per share and revenue of $680.2550 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 5, 2026 at 5:00 PM ET.

Envista (NYSE:NVST) last released its earnings results on Wednesday, October 29th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. The company had revenue of $669.90 million for the quarter, compared to analysts’ expectations of $639.49 million. Envista had a net margin of 0.58% and a return on equity of 5.90%. The firm’s revenue was up 11.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.12 EPS. On average, analysts expect Envista to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Envista Stock Performance

NVST opened at $24.09 on Thursday. The company has a 50 day simple moving average of $22.25 and a two-hundred day simple moving average of $21.01. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.37 and a quick ratio of 2.02. The firm has a market cap of $3.96 billion, a P/E ratio of 267.64, a PEG ratio of 1.07 and a beta of 0.99. Envista has a 1-year low of $14.22 and a 1-year high of $25.41.

Hedge Funds Weigh In On Envista

Institutional investors have recently added to or reduced their stakes in the company. Alliancebernstein L.P. raised its holdings in shares of Envista by 34.0% during the 2nd quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after acquiring an additional 1,547,656 shares in the last quarter. Deerfield Management Company L.P. grew its holdings in shares of Envista by 3.5% in the third quarter. Deerfield Management Company L.P. now owns 2,294,036 shares of the company’s stock valued at $46,730,000 after purchasing an additional 78,191 shares in the last quarter. Holocene Advisors LP bought a new stake in Envista in the second quarter worth $43,936,000. AQR Capital Management LLC raised its stake in Envista by 7.2% during the second quarter. AQR Capital Management LLC now owns 1,555,211 shares of the company’s stock valued at $30,389,000 after purchasing an additional 104,080 shares in the last quarter. Finally, Balyasny Asset Management L.P. purchased a new stake in Envista during the third quarter valued at $24,260,000.

Analysts Set New Price Targets

Several brokerages recently weighed in on NVST. JPMorgan Chase & Co. upped their target price on shares of Envista from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Tuesday, December 16th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Envista in a research note on Monday, December 29th. Stifel Nicolaus set a $25.00 target price on Envista in a research note on Thursday, October 30th. Mizuho set a $24.00 price target on Envista and gave the stock a “neutral” rating in a report on Tuesday, January 20th. Finally, Wall Street Zen upgraded Envista from a “buy” rating to a “strong-buy” rating in a research note on Monday. Five equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Envista currently has an average rating of “Hold” and an average price target of $22.17.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.